| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,488 |
3,424 |
$200K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,926 |
1,882 |
$191K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,535 |
2,425 |
$114K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
990 |
989 |
$83K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
764 |
764 |
$64K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
708 |
701 |
$56K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
496 |
496 |
$45K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
882 |
871 |
$45K |
| 90461 |
|
1,072 |
1,069 |
$37K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
3,737 |
3,731 |
$34K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,791 |
2,778 |
$29K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
190 |
189 |
$16K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
388 |
387 |
$12K |
| 92552 |
|
436 |
435 |
$10K |
| 96127 |
|
851 |
851 |
$9K |
| 99173 |
|
382 |
381 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
229 |
229 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
296 |
290 |
$4K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
172 |
169 |
$3K |
| 0072A |
|
68 |
68 |
$3K |
| 0071A |
|
50 |
50 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
94 |
94 |
$2K |
| 87081 |
|
229 |
226 |
$1K |
| 85018 |
|
674 |
673 |
$1K |
| 99188 |
|
31 |
31 |
$806.00 |
| 87634 |
|
13 |
13 |
$804.96 |
| 99050 |
|
17 |
17 |
$281.52 |
| 92551 |
|
12 |
12 |
$119.16 |
| 81003 |
|
27 |
27 |
$53.46 |